Viewing Study NCT00533520


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-03-09 @ 4:51 PM
Study NCT ID: NCT00533520
Status: COMPLETED
Last Update Posted: 2013-11-25
First Post: 2007-09-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Dosing Interval of Higher Doses of Ranibizumab
Sponsor: Brandon G. Busbee, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module